The pathophysiology of IO in MDS patients results from the underlying disease process (ineffective erythropoiesis, with attendant hepcidin suppression), genetic factors (e.g. SF3B1), as well as iron accumulation due to transfusion. Here, SF3B1 is linked to myelodysplastic syndrome.